UNSPSC 51351627: Estradiol valerate

This classification denotes a therapeutic estradiol with the molecular formula C23H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OKG364O896, chemically known as 3,17-epidihydroxyoestratriene but more generally known as estradiol valerate, which bears US NIH Compound Identifier 5757. European Medicines Agency schedules Estradiol valerate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07245MIG.

UNSPSC 51351627 Estradiol valerate is a Commodity-tier code for a specific pharmaceutical product — estradiol valerate, a synthetic estrogen used in hormone replacement therapy and contraceptive formulations. State and local governments procure this drug primarily through public health departments, corrections agencies, and health clinics serving Medicaid populations and uninsured patients. The product is typically solicited as part of bulk pharmaceutical purchasing, either standalone or bundled with other hormone therapies and related medications. Issuing bodies include state health departments, county health systems, correctional facilities, and public hospital networks that maintain formularies and negotiate volume pricing with suppliers or group purchasing organizations.

The source materials contain no recent state and local contract opportunities under this code, so market activity cannot be characterized by geography, issuing-body concentration, or representative recent solicitations. Without posted RFPs, RFQs, IFBs, or ITBs naming estradiol valerate or this code, the current procurement landscape under UNSPSC 51351627 remains opaque to business development screening.